glp-1 drug boom Weight-Loss Sales Slow In May, Mounjaro Still Leads The Pack, #GLP1 #Semaglutide #Mounjaro #Ozempic #Wegovy #WeightLossDrugs #Pharma #IndiaPharma #Healthcare #ObesityTreatment #StockMarket This gentle Chart: 1 in 8 Americans
Description
Todays showdown is between Ozempic and Trulicity in the SUSTAIN-7 clinical trial
What are the possible side effects of Wegovy
doi: 10.1172/JCI59903
P = 0.21) (254)
Points represent beta coefficients in Kg and error bars represent the 95% confidence intervals
A 2024 study suggests injectable semaglutide leads to more weight loss in real-world settings
